Stay Connected. Be the first to hear about upcoming initiatives.
We respect your privacy and take protecting it seriously. Learn more in our Privacy Policy.
Headquarters
25 Massachusetts Avenue NWSuite 730
Washington, D.C. 20001
Phone: 202.864.5920
Fax: 202.864.5930
San Francisco Office
214 Grant AvenueSuite 325
San Francisco, CA 94108
CVCs Committed To Remaining Active Amid COVID-19
blog, Corporate Venture /by NVCA Corporate Venture Group2020 has been a turbulent and unprecedented year. But startups have benefited from corporate venture capital (CVC) activity, and CVC will help the country on the road to economic recovery. Many would expect that if deal activity falls across the venture capital industry due to an economic downturn or other developments, deal activity with CVC […]
NVCA Member Spotlight: IU Ventures
blog, Ecosystems, Member Spotlight /by Cassie Ann KiggenWelcome to our Member Spotlight series where we give a profile overview of our many diverse members. For this deep dive, we spoke to Teri Willey, Executive Director of IU Ventures, and Samantha Ginther, Senior Associate & Head of Platform for IU Ventures.
NVCA 2020 Outstanding Service Award: Terry McGuire
blog /by Cassie Ann KiggenDue to COVID-19, NVCA was disappointed that we were not be able to celebrate in-person and recognize our VC Award winners at the 2020 Leadership Gala in San Francisco on March 12. In lieu of speeches, we are sharing the incredible achievements of our winners through a blog series highlighting the award recipients’ work and […]
Return to Work: Preparing for the Future Amid COVID-19
blog /by Latham & WatkinsCompanies planning to reopen offices face numerous challenges, including how to handle employee illness, privacy rights, and more. Companies preparing for a return to work amid the ongoing COVID-19 pandemic face a number of important HR and employment issues, including complying with federal, state, and local regulations; meeting industry-specific requirements; and adopting a return-to-work plan. […]
8 VC-Backed Startups Helping Treat COVID-19
blog, Public Policy /by Devin MillerAs the COVID-19 pandemic continues to impact the world, many U.S. VC-backed startups are helping fight the virus by developing, testing, and implementing treatments that can manage, alleviate, or even prevent the symptoms of COVID-19. The venture industry is proud to support these innovative companies by providing capital and strategic guidance that is essential to […]
Finding New Mountains: Toyota AI Ventures’ Mission of Discovery
blog, Corporate Venture /by Jim AdlerJim Adler, founding managing director of Toyota AI Ventures, recently gave a popular members-only talk on CVC structures and strategies, in which he shared how TAIV was organized and how his team arrived at its effective model. Now, he has published the first in a series of posts discussing this mission and approach. Please check […]
NVCA 2020 Excellence in Healthcare Innovation Award: Dr. Beth Seidenberg
blog /by Cassie Ann KiggenDue to COVID-19, NVCA was disappointed that we were not be able to celebrate in-person and recognize our VC Award winners at the 2020 Leadership Gala in San Francisco on March 12. In lieu of speeches, we are sharing the incredible achievements of our winners through a blog series highlighting the award recipients’ work and […]
NVCA Member Spotlight: Centana Growth Partners
blog, Ecosystems, Member Spotlight /by Cassie Ann KiggenWelcome to our Member Spotlight series where we give a profile overview of our many diverse members. For this deep dive, we spoke to Ben Cukier and Eric Byunn, Co-Founding Partners of Centana Growth Partners.
NVCA Member Spotlight: ForgePoint Capital
blog, Ecosystems, Member Spotlight /by Cassie Ann KiggenWelcome to our Member Spotlight series where we give a profile overview of our many diverse members. For this deep dive, we spoke to Alberto Yepez, Managing Director of ForgePoint Capital, and a former board member of NVCA.
How 10 VC-Backed Startups are Combating COVID-19
blog, Public Policy /by Devin MillerMany of America’s startups are currently researching and producing advanced technologies needed to fight COVID-19. Nimble, high-growth companies have frequently re-defined the boundaries of science and technology, and many startups are using their capabilities and expertise to find and develop the technology-driven solutions needed to get past this pandemic.